Standard BioTools Statistics
Total Valuation
LAB has a market cap or net worth of $432.04 million. The enterprise value is $172.17 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LAB has 378.99 million shares outstanding. The number of shares has increased by 346.24% in one year.
| Current Share Class | 378.99M |
| Shares Outstanding | 378.99M |
| Shares Change (YoY) | +346.24% |
| Shares Change (QoQ) | +0.81% |
| Owned by Insiders (%) | 1.46% |
| Owned by Institutions (%) | 48.08% |
| Float | 238.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.31 |
| Forward PS | 2.45 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.70, with a Debt / Equity ratio of 0.07.
| Current Ratio | 5.70 |
| Quick Ratio | 4.95 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -40.64 |
Financial Efficiency
Return on equity (ROE) is -43.75% and return on invested capital (ROIC) is -21.99%.
| Return on Equity (ROE) | -43.75% |
| Return on Assets (ROA) | -18.01% |
| Return on Invested Capital (ROIC) | -21.99% |
| Return on Capital Employed (ROCE) | -24.66% |
| Revenue Per Employee | $213,242 |
| Profits Per Employee | -$226,038 |
| Employee Count | 818 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, LAB has paid $573,000 in taxes.
| Income Tax | 573,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.62% in the last 52 weeks. The beta is 1.62, so LAB's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | -57.62% |
| 50-Day Moving Average | 1.33 |
| 200-Day Moving Average | 1.77 |
| Relative Strength Index (RSI) | 43.83 |
| Average Volume (20 Days) | 1,677,286 |
Short Selling Information
The latest short interest is 13.50 million, so 3.56% of the outstanding shares have been sold short.
| Short Interest | 13.50M |
| Short Previous Month | 12.85M |
| Short % of Shares Out | 3.56% |
| Short % of Float | 5.65% |
| Short Ratio (days to cover) | 6.69 |
Income Statement
In the last 12 months, LAB had revenue of $174.43 million and -$184.90 million in losses. Loss per share was -$0.52.
| Revenue | 174.43M |
| Gross Profit | 84.26M |
| Operating Income | -134.76M |
| Pretax Income | -118.58M |
| Net Income | -184.90M |
| EBITDA | -117.90M |
| EBIT | -134.76M |
| Loss Per Share | -$0.52 |
Full Income StatementBalance Sheet
The company has $292.87 million in cash and $33.00 million in debt, giving a net cash position of $259.88 million or $0.69 per share.
| Cash & Cash Equivalents | 292.87M |
| Total Debt | 33.00M |
| Net Cash | 259.88M |
| Net Cash Per Share | $0.69 |
| Equity (Book Value) | 471.72M |
| Book Value Per Share | 1.25 |
| Working Capital | 309.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$143.45 million and capital expenditures -$8.36 million, giving a free cash flow of -$151.81 million.
| Operating Cash Flow | -143.45M |
| Capital Expenditures | -8.36M |
| Free Cash Flow | -151.81M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
Gross margin is 48.31%, with operating and profit margins of -77.25% and -79.62%.
| Gross Margin | 48.31% |
| Operating Margin | -77.25% |
| Pretax Margin | -79.29% |
| Profit Margin | -79.62% |
| EBITDA Margin | -67.59% |
| EBIT Margin | -77.25% |
| FCF Margin | n/a |
Dividends & Yields
LAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -346.24% |
| Shareholder Yield | n/a |
| Earnings Yield | -42.80% |
| FCF Yield | -35.14% |
Analyst Forecast
The average price target for LAB is $2.88, which is 152.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.88 |
| Price Target Difference | 152.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 7.98% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LAB has an Altman Z-Score of 0.64 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.64 |
| Piotroski F-Score | 5 |